Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05546580
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2022-09-15
Brief Title:
Study of Iadademstat and Gilteritinib in Patients With RR AML With FMS-like Tyrosine Kinase Mutation FLT3 Mut
Sponsor:
Oryzon Genomics SA
Organization:
Oryzon Genomics SA
Organization Data
Organization:
Oryzon Genomics SA
Class:
INDUSTRY
Study ID:
CL04-ORY-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oryzon Genomics SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None